about
Functional amyloid formation within mammalian tissue.AP-1 and KIF13A coordinate endosomal sorting and positioning during melanosome biogenesisFunctions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomesBLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organellesThe tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesisMelanosomes--dark organelles enlighten endosomal membrane transportGolgi recruitment of GRIP domain proteins by Arf-like GTPase 1 is regulated by Arf-like GTPase 3.tGolgin-1 (p230, golgin-245) modulates Shiga-toxin transport to the Golgi and Golgi motility towards the microtubule-organizing centreCharacterization of mouse tGolgin-1 (golgin-245/trans-golgi p230/256 kD golgin) and its upregulation during oligodendrocyte developmentNuclear translocation of urokinase-type plasminogen activatorElectron tomography of early melanosomes: implications for melanogenesis and the generation of fibrillar amyloid sheets.SLC35D3 delivery from megakaryocyte early endosomes is required for platelet dense granule biogenesis and is differentially defective in Hermansky-Pudlak syndrome models.TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentationBLOC-1 and BLOC-3 regulate VAMP7 cycling to and from melanosomes via distinct tubular transport carriersCell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes.Mutations in or near the transmembrane domain alter PMEL amyloid formation from functional to pathogenicCis and trans regulatory mechanisms control AP2-mediated B cell receptor endocytosis via select tyrosine-based motifsDual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family.Pleiotropic platelet defects in mice with disrupted FOG1-NuRD interactionMechanisms of protein delivery to melanosomes in pigment cells.Darkness descends with two Rabs.Protein targeting by tyrosine- and di-leucine-based signals: evidence for distinct saturable componentsIdentifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments.Presentation of phagocytosed antigens by MHC class I and II.Melanoregulin (MREG) modulates lysosome function in pigment epithelial cellsEating thyself toward the dark side?N-terminal domains elicit formation of functional Pmel17 amyloid fibrilsA novel splice variant of Pmel17 expressed by human melanocytes and melanoma cells lacking some of the internal repeats.Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry.Organelle biogenesis: en BLOC exchange for RAB32 and RAB38.A cytoplasmic sequence in human tyrosinase defines a second class of di-leucine-based sorting signals for late endosomal and lysosomal delivery.Pink Light on Mitochondria in Autoimmunity and Parkinson Disease.H-2RIIBP expressed from a baculovirus vector binds to multiple hormone response elements.Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice.Loci associated with skin pigmentation identified in African populations.A role for GRIP domain proteins and/or their ligands in structure and function of the trans Golgi network.An alarming trend within the biological/biomedical research literature toward the citation of review articles rather than the primary research papers.
P50
Q21092782-9BB7E201-91A9-4980-BC75-7A5603DA1865Q24308858-092A3100-8653-48FD-B257-F59A1AA0AB79Q24323356-7F8CFAD9-7DEA-42F8-ADD7-B713D294CC08Q24337651-DA1C8377-E7AA-43BE-96DC-0C949102684EQ24338990-C8DCE058-3ADA-41BC-A4A4-54B7E0D34EE1Q24647195-84841DC7-97E0-4AB2-896A-DE921392B343Q27936914-B2C6764F-308B-4E7D-A22A-923497F1279EQ28248461-39FCCA8F-6612-4BBE-978D-04D985B83226Q28591700-E66BE28C-0D61-4D7E-8D16-10CB6937006AQ30482426-FA5E9B2D-5826-4AFA-A4D2-434B3377CB85Q30485074-15DADE7C-9611-4941-A301-DC5F7E24EB8EQ30521118-FC5C1496-4BE1-417C-B650-C98B49842BF7Q30596786-4A1498B6-B08E-49F1-867A-60A590719DA8Q30793347-C525CDBB-53AA-4A87-A246-B8F090857C71Q33613085-0D1D9BD0-963E-46FB-93FB-335605EDA015Q34031196-B77F08CE-A270-401A-ABC2-A8D309576FD1Q34571456-2DAE3EDF-8123-47F9-B7BD-83CD38349F28Q34886367-4B1F6DF9-5C44-4D34-B34E-EE2A45BEE2A7Q35358944-C1E9E34B-3508-4394-9440-3C0220C41325Q35604075-C5B50A94-8044-47A8-908F-D4ABA30F39EBQ35936316-4B3B9772-AE2E-4586-801F-D93F4E5045D0Q36119087-1E4DC344-2E2E-4EE6-9B10-A549702288E9Q36237576-77DEC495-0600-481D-8AEF-B379CFD8E452Q36358673-B3E37506-8D75-4AF4-8247-26B99F9CAC13Q36382769-E443C0FC-18EC-4B17-A843-AD83009AD000Q36514286-B37873D3-D69B-44DB-B312-18FCCC2B1F19Q37155498-45E1862F-C9E2-4616-B37D-A92886CD8E16Q37412838-FE90102A-7503-45A0-89D8-56EB70E37E8BQ37467613-5790F4BB-9FF3-4EC3-AC88-8E83D46625A9Q37476322-B0E20359-29ED-4DC3-A643-FE3C21534375Q37576241-00F8742E-16D9-4038-B1F1-FFAD216FC08EQ39240686-0401FCB3-A791-4812-A034-2505DCD1B801Q40959249-7F91C290-2B41-403E-881F-416EE3AD18FEQ41468640-C31C5A39-7B82-4D9D-9BFC-08D746C97BB3Q41641361-8269142D-0021-4890-8114-FCCC18F8DE83Q41653246-BC71578D-44AD-416B-AC88-61C9E3036A80Q42133744-4BE3C292-6025-4E04-A083-7D136A4378E2Q43924342-EA945A0C-B2C9-4653-8F8F-41B6B34FF228Q44586572-B81414C9-8F48-44F3-A2C3-4B380B11C3DFQ45332094-E3724162-14E4-4FCE-BEF6-24DF499ED6C9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael S. Marks
@ast
Michael S. Marks
@en
Michael S. Marks
@es
Michael S. Marks
@sl
type
label
Michael S. Marks
@ast
Michael S. Marks
@en
Michael S. Marks
@es
Michael S. Marks
@sl
prefLabel
Michael S. Marks
@ast
Michael S. Marks
@en
Michael S. Marks
@es
Michael S. Marks
@sl
P106
P1153
7201370713
P21
P31
P496
0000-0001-7435-7262